GlassScriptPhysician profile
Crystal Shen
NPI 1336858323
$1,537.08
in general payments reported to CMS, 2019-2025
12 companies · $303 in 2025
The $303 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $140 · 2023: $251 · 2024: $844 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,397.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $355.50 | 2024-2025 | Repatha, Repatha, Otezla |
| Philips North America LLC | $321.75 | 2023-2024 | (5044) Mcot, (Ck4) Mcot |
| Exact Sciences Corporation | $283.05 | 2023-2025 | Cologuard Collection Kit |
| Merz North America, INC. | $139.68 | 2022 | |
| Lilly USA, LLC | $99.43 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $78.45 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $72.72 | 2023-2025 | |
| Glaxosmithkline, LLC. | $54.10 | 2024-2025 | Trelegy Ellipta, Arexvy |
| Merck Sharp & Dohme LLC | $39.71 | 2024 | M-M-R II, Gardasil 9, Gardasil |
| Phadia US INC. | $39.15 | 2024-2025 | Immunocap |
| Abbvie INC. | $35.02 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $18.52 | 2024 | Airsupra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Shen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.